The paper focuses on the fundamental debate that is going on in Europe and the United States about whether genes and genetic diagnostic methods are to be regarded as inventions or subject matter eligible for patent protection, or whether they are discoveries or principles of nature and thus excluded from patentability.
For decades, cloning remained within the realms of science fiction. The idea that instead of combining a sperm and an egg, a new human could be made from a single cell taken from an adult, seemed completely absurd. But that all changed in February 1997, when the Roslin Institute introduced the world to Dolly the sheep - the first animal cloned from an adult. Ever since Dolly, scientists have been continuing to experiment with cloning animals. So far, they have succeeded in cloning sheep, cattle, pigs, goats and mice, fuelling the belief that humans could be next.
Científicos en EE.UU. desarrollan un sistema de comunicación entre células utilizando un virus como mensajero. El mecanismo podría llevar en el futuro a tejidos que se regeneran y a nuevos biocombustibles.
U.S. government agencies recruiting scientists and other experts to serve on advisory panels should be asking for more detailed disclosures of potential conflicts of interest. That's just one of the take-home messages from a report released today by The Keystone Center, a Colorado-based think tank.
Scientists, engineers, and a public official are accused of having carried out a superficial risk analysis and of having provided the townsfolk with a false sense of security a week before the quake struck.
The European Food Safety Authority has concluded that a recent paper raising concerns about the potential toxicity of genetically modified (GM) maize NK603 and of a herbicide containing glyphosate is of insufficient scientific quality to be considered as valid for risk assessment.
The Presidential Commission for the Study of Bioethical Issues publicly released the results of its investigation into the U.S. Public Health Service (PHS) studies conducted in Guatemala in the 1940s, after fully briefing and delivering its report to the White House.
La historia de la semilla se ha convertido en una de las pérdidas, el control, la dependencia y la deuda. Ha sido escrita para obtener beneficios vasto de nuestro sistema alimentario, no importa cuál sea el costo real. Es hora de cambiar la historia.
Producido por la Fundación Gaia y la Red de Biodiversidad de África, en colaboración con MELCA Etiopía, Internacional Navdanya y GRAIN.
In a recent decision (Monsanto Technology LLC v Cefetra BV and Others), the Court of Justice of the European Union declared that patent protection for gene patents will only extend to gene sequences which are performing the specific function for which they were patented. The decision of the Court is the first-ever judicial assessment of the extent to which European patent law will protect gene patents.
New rules adopted by the Federal Communications Commission (FCC) have an appreciable impact on the way that hospitals, nursing homes and other inpatient and outpatient health care providers will monitor their patients in the future. The new FCC rules enable the use of Medical Body Area Networks (MBANs). MBANs are low-power wideband networks consisting of multiple body-worn sensors that transmit various patient data to a control device that collects data from the sensors.